VYNE Therapeutics
VYNE
#9861
Rank
HK$0.16 B
Marketcap
HK$10.94
Share price
-2.08%
Change (1 day)
-46.87%
Change (1 year)

EPS for VYNE Therapeutics (VYNE)

EPS in 2023 (TTM): -HK$86.51

According to VYNE Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$85.65. In 2022 the company made an earnings per share (EPS) of -HK$56.87 an increase over its 2021 EPS that were of -HK$201.09.

EPS history for VYNE Therapeutics from 2017 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$86.5152.12%
2022-HK$56.87-71.72%
2021-HK$201.09-84.19%
2020-HK$1,272-26.29%
2019-HK$1,72628.75%
2018-HK$1,34110.79%
2017-HK$1,210

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$16.91-80.25%๐Ÿ‡บ๐Ÿ‡ธ USA